Methylphenidate shortage ‘resolving’: TGA

Global shortages of methylphenidate modified-release medications continue to improve and stabilise, regulator says  Supply shortages of multiple strengths of medications used to treat attention deficit hyperactivity disorder (ADHD) are expected to be resolved by late June, the Therapeutic Goods Administration (TGA) reports.   In an update published on Tuesday (21 April 2026), the regulator noted that during 2024 to 2025, pharmaceutical